Baxter (BAX) Reports Q1 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Baxter (BAX) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Will BAX's Q1 Earnings Improve Following Transformation Completion?
Baxter's first-quarter results are likely to reflect the favorable impact of kidney care sales. Growth in infusion therapies, pharmaceuticals and patient support systems to continue.
Baxter Stock Likely to Gain Following the Introduction of Voalte Linq
At the 2025 HIMSS Global Healthcare Conference, BAX unveils its Voalte Linq device, powered by Scotty assistant, a voice-activated technology.
Kontoor Brands CEO Scott Baxter sits down with Jim Cramer
Kontoor Brands Chair, President, and CEO Scott Baxter joins 'Mad Money' host Jim Cramer to talk acquiring Helly Hansen, international business, and more.
BAX Stock Surges Following Q4 Earnings & Sales Beat, Margins Decline
Baxter reports better-than-expected fourth-quarter results. However, the company's gross and operating margins contract.
Baxter International Inc. (BAX) Q4 2024 Earnings Conference Call Transcript
Baxter International Inc. (BAX) Q4 2024 Earnings Conference Call Transcript
Baxter Q4 Earnings Beat Expectations, Issues Strong 2025 Outlook
On Thursday, Baxter International Inc. BAX reported a fourth-quarter 2024 adjusted EPS of 58 cents, beating the management guidance of 50 cents-53 cents and the Wall Street estimate of 52 cents.
Baxter (BAX) Reports Q4 Earnings: What Key Metrics Have to Say
The headline numbers for Baxter (BAX) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Baxter forecasts 2025 profit above estimates on medical device demand; shares rise
Baxter International on Thursday forecast 2025 profit above Wall Street estimates banking on strong sales of its medical devices, sending the company's shares up 7% in premarket trade.
Will BAX's Q4 Earnings Reflect Its Efforts to Counter Headwinds?
Baxter might have faced fourth-quarter hurdles from Hurricane Helene. However, it expects growth in infusion therapies, pharmaceuticals and patient support systems to have driven recovery.
Countdown to Baxter (BAX) Q4 Earnings: Wall Street Forecasts for Key Metrics
Evaluate the expected performance of Baxter (BAX) for the quarter ended December 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Baxter CEO José Almeida to retire after near decade-long tenure
Medical products maker Baxter International said on Monday its CEO José Almeida will retire effective immediately, after nearly a decade as the company's top boss.
